Band 3, the human red cell chloride/bicarbonate anion exchanger (AE1, SLC4A1), in a structural context.

Reinhart A F Reithmeier, Joseph R Casey, Antreas C Kalli, Mark S P Sansom, Yilmaz Alguel, So Iwata

Journal: Biochimica et biophysica acta 2016;1858(7 Pt A):1507-32

PMID: 27058983

Abstract

The crystal structure of the dimeric membrane domain of human Band 3(1), the red cell chloride/bicarbonate anion exchanger 1 (AE1, SLC4A1), provides a structural context for over four decades of studies into this historic and important membrane glycoprotein. In this review, we highlight the key structural features responsible for anion binding and translocation and have integrated the following topological markers within the Band 3 structure: blood group antigens, N-glycosylation site, protease cleavage sites, inhibitor and chemical labeling sites, and the results of scanning cysteine and N-glycosylation mutagenesis. Locations of mutations linked to human disease, including those responsible for Southeast Asian ovalocytosis, hereditary stomatocytosis, hereditary spherocytosis, and distal renal tubular acidosis, provide molecular insights into their effect on Band 3 folding. Finally, molecular dynamics simulations of phosphatidylcholine self-assembled around Band 3 provide a view of this membrane protein within a lipid bilayer.

Copyright © 2016 Elsevier B.V. All rights reserved.

Address: Department of Biochemistry, 1 King's College Circle, University of Toronto, Toronto M5S 1A8, Canada. Electronic address: [email protected].; Department of Biochemistry, Membrane Protein Disease Research Group, University of Alberta, Edmonton, Alberta T6G 2H7, Canada.; Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.; Division of Molecular Biosciences, Imperial College London, London, SW7 2AZ, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.